News

Researchers at the Institute of Biochemistry have successfully overcome drug-resistance in malignant melanoma cells. FAU has now filed a patent application for the new therapeutic approach.

We eat salt every day, sometimes more and sometimes less, but often too much. However, the impact of salt on intestinal bacteria has not been studied up to now. A research team of the Chair of Neurology recently discovered that table salt reduces the number of lactobacilli in the intestinal tract.

Researchers at FAU identify the molecular mechanisms involved in the activation of the immune system.

Stroke, depression and dementia: These are associated with micro-failures in brain communication. FAU researchers are looking at what exactly happens in these situations and are hoping to identify possible ways of preventing permanent brain damage and speeding up the healing processes.

FAU researchers and their colleagues at the University of Bayreuth investigated whether an artificial silk protein developed in the laboratory could be suitable for engineering cardiac tissue.

Neuroscientists have joined forces with human geneticists at Otto von Guericke University in Magdeburg to develop a new approach to the treatment of rare genetic conditions such as Noonan syndrome.

In future, researchers in Erlangen will take into account a little-noted factor in the development of diseases: physics.

The Digital Health Innovation Platform (d.hip) was established by an alliance between university medicine, industry, and science for the purpose of accelerating the digitalization of medicine and healthcare.

Eleven German biobank sites are joining forces in the German Biobank Alliance, smoothing the way for a national and Europe-wide exchange of data and bio-samples. The Chair of Medical Informatics is one of the IT centres of expertise in the network.